APOE and Alzheimer disease: ApoE isoforms exhibit differential binding affinities for LRP1, with apoE3 generally demonstrating optimal receptor interactions compared to apoE2 and apoE4; the impaired binding of apoE4 to LRP1 can lead to reduced clearance efficiency of Aβ, enhancing AD pathology [21, 22].